News You and Your Patients Can Use: New Dosing Option for UCB’s Bimekizumab Now Commercially Available for PsO, PsA, and HS
Single-injection 2mL prefilled syringes and autoinjectors containing 320mg of bimekizumab-bkzx (Bimzelx, UCB) are now commercially available, UCB reports. These are in addition to the currently available 1mL devices, each containing 160mg of bimekizumab-bkzx. With the new presentations, patients requiring a 320mg dose of bimekizumab-bkzx will have options for single-injection administration. The approval of the 320mg […]